1. Home
  2. ENVA vs TVTX Comparison

ENVA vs TVTX Comparison

Compare ENVA & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$175.60

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$52.39

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
TVTX
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
5.3B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
ENVA
TVTX
Price
$175.60
$52.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
15
Target Price
★ $238.50
$75.21
AVG Volume (30 Days)
285.2K
★ 1.5M
Earning Date
10-22-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
55.05
★ 92.89
EPS
★ 7.45
N/A
Revenue
★ $3,151,653,000.00
N/A
Revenue This Year
$158.78
$47.65
Revenue Next Year
$17.63
$49.39
P/E Ratio
$24.17
★ N/A
Revenue Growth
★ 18.58
N/A
52 Week Low
$115.06
$22.59
52 Week High
$267.45
$68.73

Technical Indicators

Market Signals
Indicator
ENVA
TVTX
Relative Strength Index (RSI) 40.49 38.26
Support Level $167.09 $41.75
Resistance Level $176.20 $59.93
Average True Range (ATR) 4.96 2.31
MACD 2.19 0.08
Stochastic Oscillator 44.47 31.09

Price Performance

Historical Comparison
ENVA
TVTX

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: